Afshar-Sterle Shoukat |
A tuft cell - ILC2 signaling circuit provides therapeutic targets to inhibit gastric metaplasia and tumor development
|
Amiet Nicole |
PTP1B deficiency alleviates T cell exhaustion by promoting JAK/STAT signalling
|
Aplenc Anna |
Targeting core super-enhancer circuitries of anaplastic large cell lymphoma by rational design of IRF4 degrader drugs
|
Aung* Myint |
Investigating disease mechanisms and targetable dependencies in γδ T cell lymphoma using novel STAT5B-driven pre-clinical models
|
Balestrero Federica |
eNAMPT-induced breast cancer cell reprogramming towards an invasive and metastatic phenotype
Exploring the role of eNAMPT (extracellular nicotinamide phosphoribosyltransferase) in tumoral progression
|
Baloyan David |
A tuft cell - ILC2 signaling circuit provides therapeutic targets to inhibit gastric metaplasia and tumor development
|
Beauchamp Elspeth |
Role of CHAF1B in interferon responses in myeloproliferative neoplasms
Characterization of the SLFN5 Role in the Regulation of Immune Cells and Natural Killer (NK) Cells Anti-Tumor Activity
|
Behren Andreas |
Combination immunotherapy in patients with rare cancers
|
Bekiaris Vasileios |
Investigating disease mechanisms and targetable dependencies in γδ T cell lymphoma using novel STAT5B-driven pre-clinical models
|
Benech Nicolas |
A new effector T cell subset leading to cancer
|
Berger Walter |
Investigating disease mechanisms and targetable dependencies in γδ T cell lymphoma using novel STAT5B-driven pre-clinical models
|
Berindan-Neagoe Ioana |
Interconnection between miR-21, miR-181a, miR-155 and their target immune response genes: IL1, IL6, IL17, and TNFalpha in different subtypes of breast cancer
Cytokines profiling and their involvement in the ovarian adenocarcinoma tumour microenvironment
The role of the cytokines-related miRNAs in smoking female NSCLC; a comparative female versus male study
|
Bernardini Marcus |
CD103-expressing CD56+ regulatory ILCs suppresses intratumoural T cells and are associated with poor clinical outcomes
|
Bianca Matthew |
Cancer cell SMAD4 mutations drive increased myeloid cell infiltration in the tumor microenvironment of pancreatic ductal adenocarcinoma
|
Bica Cecilia |
Cytokines profiling and their involvement in the ovarian adenocarcinoma tumour microenvironment
The role of the cytokines-related miRNAs in smoking female NSCLC; a comparative female versus male study
Interconnection between miR-21, miR-181a, miR-155 and their target immune response genes: IL1, IL6, IL17, and TNFalpha in different subtypes of breast cancer
|
Bielawska Anna |
The influence of Scorzonera hispanica seeds on TNF-α and IL-8 concentrations in breast cancer cells
The anti-proliferative and anti-inflammatory effect of a novel
4-thiazolidinone derivative in combination with anti-HER2 antibodies in human AGS gastric cancer cells
|
Bielawski Krzysztof |
The effects of Scorzonera hispanica seeds on the cellular signaling pathways in MCF-7 breast cancer cells
The influence of Scorzonera hispanica seeds on TNF-α and IL-8 concentrations in breast cancer cells
The anti-proliferative and anti-inflammatory effect of a novel
4-thiazolidinone derivative in combination with anti-HER2 antibodies in human AGS gastric cancer cells
|
Bonder Claudine |
Re-evaluating the tumour vasculature to improve cancer outcomes
|
Borden Katherine |
Cancer cells subvert the RNA metabolism machinery to re-write the message and reprogramme the cell
|
Braicu Cornelia |
Interconnection between miR-21, miR-181a, miR-155 and their target immune response genes: IL1, IL6, IL17, and TNFalpha in different subtypes of breast cancer
Cytokines profiling and their involvement in the ovarian adenocarcinoma tumour microenvironment
The role of the cytokines-related miRNAs in smoking female NSCLC; a comparative female versus male study
|
Britt Kara |
The role of the immune system in breast cancer risk and early tumour formation
|
Brooks David |
Interferon-mediated regulation of T cell function and immunotherapy in cancer
|
Buchert Michael |
A tuft cell - ILC2 signaling circuit provides therapeutic targets to inhibit gastric metaplasia and tumor development
|
Budisan Liviuta |
The role of the cytokines-related miRNAs in smoking female NSCLC; a comparative female versus male study
|
Campbell Nicole |
Interferon epsilon limits ovarian cancer metastasis via regulation of peritoneal immune cells
|
Carli Annalisa LE |
A tuft cell - ILC2 signaling circuit provides therapeutic targets to inhibit gastric metaplasia and tumor development
|
Chen Anna |
TYK2 inhibition causes not only apoptosis but also a marked anti-tumor
immune response in Anaplastic Large Cell Lymphoma
|
Chira Sergiu |
The role of the cytokines-related miRNAs in smoking female NSCLC; a comparative female versus male study
|
Chiroi Paul |
Interconnection between miR-21, miR-181a, miR-155 and their target immune response genes: IL1, IL6, IL17, and TNFalpha in different subtypes of breast cancer
|
Chisanga David |
A tuft cell - ILC2 signaling circuit provides therapeutic targets to inhibit gastric metaplasia and tumor development
|
Chung Douglas |
CD103-expressing CD56+ regulatory ILCs suppresses intratumoural T cells and are associated with poor clinical outcomes
|
Ciccone Valerio |
Exploring the role of eNAMPT (extracellular nicotinamide phosphoribosyltransferase) in tumoral progression
|
Ciocan Cristina |
Cytokines profiling and their involvement in the ovarian adenocarcinoma tumour microenvironment
The role of the cytokines-related miRNAs in smoking female NSCLC; a comparative female versus male study
Interconnection between miR-21, miR-181a, miR-155 and their target immune response genes: IL1, IL6, IL17, and TNFalpha in different subtypes of breast cancer
|
Ciudad Maria Teresa |
Cancer cell SMAD4 mutations drive increased myeloid cell infiltration in the tumor microenvironment of pancreatic ductal adenocarcinoma
|
Clarke Blaise |
CD103-expressing CD56+ regulatory ILCs suppresses intratumoural T cells and are associated with poor clinical outcomes
|
Cohn Ronald |
STAT1 gain-of-function DNA-binding-domain mutations cause immune dysregulation in humans and mice
|
Colombo Giorgia |
Extracellular Nicotinamide Phosphoribosyltransferase (eNAMPT) neutralization impairs TNBC burden, reducing cancer cell migration and T-cell suppressive phenotype
|
Condorelli Fabrizio |
eNAMPT-induced breast cancer cell reprogramming towards an invasive and metastatic phenotype
|
Consortium CONCORD-19 |
IFN-ß ring prophylaxis to reduce SARS-CoV-2 transmission
|
Crome Sarah |
CD103-expressing CD56+ regulatory ILCs suppresses intratumoural T cells and are associated with poor clinical outcomes
|
Czarnomysy Robert |
The effects of Scorzonera hispanica seeds on the cellular signaling pathways in MCF-7 breast cancer cells
|
D'Amico Stephen |
STAT3 as a collateral dependency in KRAS mutant pancreatic cancer
|
Darcy Phil |
PTP1B deficiency alleviates T cell exhaustion by promoting JAK/STAT signalling
|
de Weerd Nicole |
Interferon epsilon limits ovarian cancer metastasis via regulation of peritoneal immune cells
|
Dudchak Rostyslav |
The anti-proliferative and anti-inflammatory effect of a novel
4-thiazolidinone derivative in combination with anti-HER2 antibodies in human AGS gastric cancer cells
|
Eckerdt Frank |
Role of CHAF1B in interferon responses in myeloproliferative neoplasms
Characterization of the SLFN5 Role in the Regulation of Immune Cells and Natural Killer (NK) Cells Anti-Tumor Activity
|
Eissmann Moritz |
A tuft cell - ILC2 signaling circuit provides therapeutic targets to inhibit gastric metaplasia and tumor development
|
Elford Alisha |
CD103-expressing CD56+ regulatory ILCs suppresses intratumoural T cells and are associated with poor clinical outcomes
|
Ernst Matthias |
A tuft cell - ILC2 signaling circuit provides therapeutic targets to inhibit gastric metaplasia and tumor development
The gp130 signaling-cascade provides therapeutic vulnerabilities for solid malignancies
|
Ferguson Sarah |
CD103-expressing CD56+ regulatory ILCs suppresses intratumoural T cells and are associated with poor clinical outcomes
|
Fesneau Olivier |
A new effector T cell subset leading to cancer
|
Fischietti Mariafausta |
Role of CHAF1B in interferon responses in myeloproliferative neoplasms
Characterization of the SLFN5 Role in the Regulation of Immune Cells and Natural Killer (NK) Cells Anti-Tumor Activity
|
Fish Eleanor |
Characterization of the SLFN5 Role in the Regulation of Immune Cells and Natural Killer (NK) Cells Anti-Tumor Activity
Role of CHAF1B in interferon responses in myeloproliferative neoplasms
IFN-ß ring prophylaxis to reduce SARS-CoV-2 transmission
|
Freeman Andrew |
Unleashing TNF cytotoxicity to enhance cancer immunotherapy
|
Garcia-Batres Carlos |
CD103-expressing CD56+ regulatory ILCs suppresses intratumoural T cells and are associated with poor clinical outcomes
|
Gearing Linden |
Interferon epsilon limits ovarian cancer metastasis via regulation of peritoneal immune cells
|
Gebhardt Thomas |
CD4 T cell immunity in cutaneous melanoma
|
Genazzani Armando |
eNAMPT-induced breast cancer cell reprogramming towards an invasive and metastatic phenotype
Exploring the role of eNAMPT (extracellular nicotinamide phosphoribosyltransferase) in tumoral progression
Extracellular Nicotinamide Phosphoribosyltransferase (eNAMPT) neutralization impairs TNBC burden, reducing cancer cell migration and T-cell suppressive phenotype
|
Ghaedi Maryam |
CD103-expressing CD56+ regulatory ILCs suppresses intratumoural T cells and are associated with poor clinical outcomes
|
Giordano Catello |
Targeting core super-enhancer circuitries of anaplastic large cell lymphoma by rational design of IRF4 degrader drugs
TYK2 inhibition causes not only apoptosis but also a marked anti-tumor
immune response in Anaplastic Large Cell Lymphoma
|
Gornowicz Agnieszka |
The effects of Scorzonera hispanica seeds on the cellular signaling pathways in MCF-7 breast cancer cells
The influence of Scorzonera hispanica seeds on TNF-α and IL-8 concentrations in breast cancer cells
The anti-proliferative and anti-inflammatory effect of a novel
4-thiazolidinone derivative in combination with anti-HER2 antibodies in human AGS gastric cancer cells
|
Gotthardt Dagmar |
Investigating disease mechanisms and targetable dependencies in γδ T cell lymphoma using novel STAT5B-driven pre-clinical models
|
Gould Jodee |
Interferon epsilon limits ovarian cancer metastasis via regulation of peritoneal immune cells
|
Grolla Ambra |
eNAMPT-induced breast cancer cell reprogramming towards an invasive and metastatic phenotype
Exploring the role of eNAMPT (extracellular nicotinamide phosphoribosyltransferase) in tumoral progression
|
Guidos Cynthia |
STAT1 gain-of-function DNA-binding-domain mutations cause immune dysregulation in humans and mice
|
Haigh Jody |
JAK/BCL2 inhibition acts synergistically with LSD1 inhibitors to selectively target ETP-ALL.
|
Halbritter Florian |
Investigating disease mechanisms and targetable dependencies in γδ T cell lymphoma using novel STAT5B-driven pre-clinical models
|
Han SeongJun |
CD103-expressing CD56+ regulatory ILCs suppresses intratumoural T cells and are associated with poor clinical outcomes
|
Hao Fang |
STAT3 as a collateral dependency in KRAS mutant pancreatic cancer
|
Harangus Antonia |
The role of the cytokines-related miRNAs in smoking female NSCLC; a comparative female versus male study
|
Harari Daniel |
Localized type I interferon therapy improves immune infiltration and PD-blockade in a mouse melanoma model
Localized type I interferon therapy improves immune infiltration and PD-blockade in a mouse melanoma model
|
Herling Marco |
Investigating disease mechanisms and targetable dependencies in γδ T cell lymphoma using novel STAT5B-driven pre-clinical models
|
Hernandez-Vargas Hector |
A new effector T cell subset leading to cancer
|
Herndler-Brandstetter Dietmar |
TYK2 inhibition causes not only apoptosis but also a marked anti-tumor
immune response in Anaplastic Large Cell Lymphoma
|
Hertzog Paul |
Interferon epsilon has tumour suppressor activities in ovarian cancer.
Interferon epsilon limits ovarian cancer metastasis via regulation of peritoneal immune cells
|
Hoffman Ronald |
Role of CHAF1B in interferon responses in myeloproliferative neoplasms
|
Hou Ye |
Role of CHAF1B in interferon responses in myeloproliferative neoplasms
|
Isacescu Ecaterina |
Interconnection between miR-21, miR-181a, miR-155 and their target immune response genes: IL1, IL6, IL17, and TNFalpha in different subtypes of breast cancer
|
Ivakine Evgueni |
STAT1 gain-of-function DNA-binding-domain mutations cause immune dysregulation in humans and mice
|
Jablonska Jadwiga |
Immunoregulatory functions of neutrophils in cancer
|
Jacquelot Nicolas |
CD103-expressing CD56+ regulatory ILCs suppresses intratumoural T cells and are associated with poor clinical outcomes
|
Jin Robbie |
Cancer cell SMAD4 mutations drive increased myeloid cell infiltration in the tumor microenvironment of pancreatic ductal adenocarcinoma
|
Johnstone Ricky |
Unleashing TNF cytotoxicity to enhance cancer immunotherapy
|
Kearney Conor |
Unleashing TNF cytotoxicity to enhance cancer immunotherapy
|
Kenner Lukas |
Targeting core super-enhancer circuitries of anaplastic large cell lymphoma by rational design of IRF4 degrader drugs
TYK2 inhibition causes not only apoptosis but also a marked anti-tumor
immune response in Anaplastic Large Cell Lymphoma
|
Kirillov Varvara |
STAT3 as a collateral dependency in KRAS mutant pancreatic cancer
|
Kosciuczuk Ewa |
Role of CHAF1B in interferon responses in myeloproliferative neoplasms
|
Kraupp Sophie |
Investigating disease mechanisms and targetable dependencies in γδ T cell lymphoma using novel STAT5B-driven pre-clinical models
|
Leitner Judith |
TYK2 inhibition causes not only apoptosis but also a marked anti-tumor
immune response in Anaplastic Large Cell Lymphoma
|
Lendzion Karolina |
The effects of Scorzonera hispanica seeds on the cellular signaling pathways in MCF-7 breast cancer cells
The influence of Scorzonera hispanica seeds on TNF-α and IL-8 concentrations in breast cancer cells
|
Lesyk Roman |
The anti-proliferative and anti-inflammatory effect of a novel
4-thiazolidinone derivative in combination with anti-HER2 antibodies in human AGS gastric cancer cells
|
Liang Huang-Chang |
Targeting core super-enhancer circuitries of anaplastic large cell lymphoma by rational design of IRF4 degrader drugs
|
List Julia |
Investigating disease mechanisms and targetable dependencies in γδ T cell lymphoma using novel STAT5B-driven pre-clinical models
|
Liu Zhe Qi |
Cancer cell SMAD4 mutations drive increased myeloid cell infiltration in the tumor microenvironment of pancreatic ductal adenocarcinoma
|
Locksley Richard M |
A tuft cell - ILC2 signaling circuit provides therapeutic targets to inhibit gastric metaplasia and tumor development
|
Look Thomas |
Targeting core super-enhancer circuitries of anaplastic large cell lymphoma by rational design of IRF4 degrader drugs
|
Luo Yu Xuan |
Enhanced IFN sensing by aggressive chronic lymphocytic leukemia cells
|
Marie Julien |
A new effector T cell subset leading to cancer
|
Matthews Jessica |
CD103-expressing CD56+ regulatory ILCs suppresses intratumoural T cells and are associated with poor clinical outcomes
|
McGaha Tracy |
Cancer cell SMAD4 mutations drive increased myeloid cell infiltration in the tumor microenvironment of pancreatic ductal adenocarcinoma
|
Merkel Olaf |
Targeting core super-enhancer circuitries of anaplastic large cell lymphoma by rational design of IRF4 degrader drugs
TYK2 inhibition causes not only apoptosis but also a marked anti-tumor
immune response in Anaplastic Large Cell Lymphoma
|
Mishra Lopa |
Targeting NASH and HCC through intrinsically disordered proteins
|
Möller Andreas |
Cytokines bound to cancer-derived extracellular vesicles impact immune cell phenotypes and metastasis
|
Montaño-Gutierrez Luis |
Investigating disease mechanisms and targetable dependencies in γδ T cell lymphoma using novel STAT5B-driven pre-clinical models
|
Moriggl Richard |
Investigating disease mechanisms and targetable dependencies in γδ T cell lymphoma using novel STAT5B-driven pre-clinical models
|
Moro Marianna |
eNAMPT-induced breast cancer cell reprogramming towards an invasive and metastatic phenotype
Exploring the role of eNAMPT (extracellular nicotinamide phosphoribosyltransferase) in tumoral progression
|
Mueller Mathias |
PTP1B deficiency alleviates T cell exhaustion by promoting JAK/STAT signalling
|
Neubauer Heidi |
Investigating disease mechanisms and targetable dependencies in γδ T cell lymphoma using novel STAT5B-driven pre-clinical models
|
Nguyen Linh |
CD103-expressing CD56+ regulatory ILCs suppresses intratumoural T cells and are associated with poor clinical outcomes
|
Nutu Andreea |
Cytokines profiling and their involvement in the ovarian adenocarcinoma tumour microenvironment
The role of the cytokines-related miRNAs in smoking female NSCLC; a comparative female versus male study
|
O’Keefe Ryan N |
A tuft cell - ILC2 signaling circuit provides therapeutic targets to inhibit gastric metaplasia and tumor development
|
Ohashi Pamela |
CD103-expressing CD56+ regulatory ILCs suppresses intratumoural T cells and are associated with poor clinical outcomes
|
Oliaro Jane |
Unleashing TNF cytotoxicity to enhance cancer immunotherapy
|
Overall Christopher |
Remodelling the interferon and chemokine activity landscape in COVID-19 and inflammatory responses by immune cell proteases and SARS-CoV-2 3Clpro main protease precision proteolysis reveals chinks in the cell's armour
|
Pal Bhupinder |
A tuft cell - ILC2 signaling circuit provides therapeutic targets to inhibit gastric metaplasia and tumor development
|
Parish Ian |
Restraint of early T cell activation by the tolerance checkpoint
|
Parker Belinda |
Uncovering opportunities for immune targeting of bone metastases
|
Perez Ricardo |
Role of CHAF1B in interferon responses in myeloproliferative neoplasms
Characterization of the SLFN5 Role in the Regulation of Immune Cells and Natural Killer (NK) Cells Anti-Tumor Activity
|
Petrenko Oleksi |
STAT3 as a collateral dependency in KRAS mutant pancreatic cancer
|
Pirker Christine |
Investigating disease mechanisms and targetable dependencies in γδ T cell lymphoma using novel STAT5B-driven pre-clinical models
|
Platanias Leonidas |
Characterization of the SLFN5 Role in the Regulation of Immune Cells and Natural Killer (NK) Cells Anti-Tumor Activity
Role of CHAF1B in interferon responses in myeloproliferative neoplasms
|
Podolak Magdalena |
The anti-proliferative and anti-inflammatory effect of a novel
4-thiazolidinone derivative in combination with anti-HER2 antibodies in human AGS gastric cancer cells
|
Poh Ashleigh |
A tuft cell - ILC2 signaling circuit provides therapeutic targets to inhibit gastric metaplasia and tumor development
|
Pop Laura |
Cytokines profiling and their involvement in the ovarian adenocarcinoma tumour microenvironment
Interconnection between miR-21, miR-181a, miR-155 and their target immune response genes: IL1, IL6, IL17, and TNFalpha in different subtypes of breast cancer
|
Prutsch Nicole |
Targeting core super-enhancer circuitries of anaplastic large cell lymphoma by rational design of IRF4 degrader drugs
TYK2 inhibition causes not only apoptosis but also a marked anti-tumor
immune response in Anaplastic Large Cell Lymphoma
|
Putoczki Tracy |
Unravelling the contribution of TNF to pancreatic cancer
|
Raduly Lajos |
Cytokines profiling and their involvement in the ovarian adenocarcinoma tumour microenvironment
The role of the cytokines-related miRNAs in smoking female NSCLC; a comparative female versus male study
|
Reich Marshall Nancy |
STAT3 as a collateral dependency in KRAS mutant pancreatic cancer
|
Roifman Chaim |
STAT1 gain-of-function DNA-binding-domain mutations cause immune dysregulation in humans and mice
|
Rot Antal |
Accelerated experimental cancer growth and altered tumour-host interactions in mice with ACKR1-deficient erythroid cells
|
Ruscetti Marcus |
Leveraging senescence-associated cytokine signaling for pancreatic cancer immunotherapy
|
Saleiro Diana |
Role of CHAF1B in interferon responses in myeloproliferative neoplasms
Characterization of the SLFN5 Role in the Regulation of Immune Cells and Natural Killer (NK) Cells Anti-Tumor Activity
|
Sangaletti Sabina |
Extracellular Nicotinamide Phosphoribosyltransferase (eNAMPT) neutralization impairs TNBC burden, reducing cancer cell migration and T-cell suppressive phenotype
|
Sayad Azin |
CD103-expressing CD56+ regulatory ILCs suppresses intratumoural T cells and are associated with poor clinical outcomes
|
Schönefeldt* Susann |
Investigating disease mechanisms and targetable dependencies in γδ T cell lymphoma using novel STAT5B-driven pre-clinical models
|
Schreiber Gideon |
Localized type I interferon therapy improves immune infiltration and PD-blockade in a mouse melanoma model
Localized type I interferon therapy improves immune infiltration and PD-blockade in a mouse melanoma model
|
Scott Ori |
STAT1 gain-of-function DNA-binding-domain mutations cause immune dysregulation in humans and mice
|
Seillet Cyril |
A tuft cell - ILC2 signaling circuit provides therapeutic targets to inhibit gastric metaplasia and tumor development
|
Sek Kevin |
PTP1B deficiency alleviates T cell exhaustion by promoting JAK/STAT signalling
|
Shaw Patricia |
CD103-expressing CD56+ regulatory ILCs suppresses intratumoural T cells and are associated with poor clinical outcomes
|
Shi Yonghong |
Enhanced IFN sensing by aggressive chronic lymphocytic leukemia cells
A tuft cell - ILC2 signaling circuit provides therapeutic targets to inhibit gastric metaplasia and tumor development
|
Shilatifard Ali |
Principles of epigenetics and chromatin in development and human disease
|
Silke John |
Unleashing TNF cytotoxicity to enhance cancer immunotherapy
|
Singer Weinberg Rona |
Role of CHAF1B in interferon responses in myeloproliferative neoplasms
|
Sorger Helena |
Investigating disease mechanisms and targetable dependencies in γδ T cell lymphoma using novel STAT5B-driven pre-clinical models
|
Spaner David |
Enhanced IFN sensing by aggressive chronic lymphocytic leukemia cells
|
Steinberger Peter |
TYK2 inhibition causes not only apoptosis but also a marked anti-tumor
immune response in Anaplastic Large Cell Lymphoma
|
Suske Tobias |
Investigating disease mechanisms and targetable dependencies in γδ T cell lymphoma using novel STAT5B-driven pre-clinical models
|
Thevin Valentin |
A new effector T cell subset leading to cancer
|
Tiganis Tony |
PTP1B deficiency alleviates T cell exhaustion by promoting JAK/STAT signalling
PTPs and STATs in cancer immunotherapy
|
Tomczyk Michal |
The effects of Scorzonera hispanica seeds on the cellular signaling pathways in MCF-7 breast cancer cells
The influence of Scorzonera hispanica seeds on TNF-α and IL-8 concentrations in breast cancer cells
|
Touaibia Mohamed |
Targeting core super-enhancer circuitries of anaplastic large cell lymphoma by rational design of IRF4 degrader drugs
|
Travelli Cristina |
Extracellular Nicotinamide Phosphoribosyltransferase (eNAMPT) neutralization impairs TNBC burden, reducing cancer cell migration and T-cell suppressive phenotype
|
Vakharia Jehan |
CD103-expressing CD56+ regulatory ILCs suppresses intratumoural T cells and are associated with poor clinical outcomes
|
Vervoort Stephin |
Unleashing TNF cytotoxicity to enhance cancer immunotherapy
|
Wagner Christina |
Investigating disease mechanisms and targetable dependencies in γδ T cell lymphoma using novel STAT5B-driven pre-clinical models
|
Wais Tamara |
Investigating disease mechanisms and targetable dependencies in γδ T cell lymphoma using novel STAT5B-driven pre-clinical models
|
Wan Yong |
Proteolytic regulation of CD73 by TRIM21 orchestrates tumor immunogenicity
|
Wang Ben |
CD103-expressing CD56+ regulatory ILCs suppresses intratumoural T cells and are associated with poor clinical outcomes
Enhanced IFN sensing by aggressive chronic lymphocytic leukemia cells
Role of CHAF1B in interferon responses in myeloproliferative neoplasms
|
Warner Kathrin |
CD103-expressing CD56+ regulatory ILCs suppresses intratumoural T cells and are associated with poor clinical outcomes
|
Watowich Stephanie |
Association of the microbiome with response and toxicity to immune checkpoint inhibitors
|
Wiede Florian |
PTP1B deficiency alleviates T cell exhaustion by promoting JAK/STAT signalling
|
Wray-McCann Georgie |
Interferon epsilon limits ovarian cancer metastasis via regulation of peritoneal immune cells
|
Yang G. Sohae |
Role of CHAF1B in interferon responses in myeloproliferative neoplasms
|
Yue Feng |
Role of CHAF1B in interferon responses in myeloproliferative neoplasms
|
Zahma Safia |
Investigating disease mechanisms and targetable dependencies in γδ T cell lymphoma using novel STAT5B-driven pre-clinical models
|
Zannikou Markella |
Characterization of the SLFN5 Role in the Regulation of Immune Cells and Natural Killer (NK) Cells Anti-Tumor Activity
|
Zanoaga Oana |
Cytokines profiling and their involvement in the ovarian adenocarcinoma tumour microenvironment
|
Zhang Xin |
Cancer cell SMAD4 mutations drive increased myeloid cell infiltration in the tumor microenvironment of pancreatic ductal adenocarcinoma
USP18 in regulation of cancer immune responses
|